Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
During crashes, passive index funds typically deliver steadier exposure and lower fees, while active funds may outperform briefly but incur higher risks and costs.
24,770 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
A coalition of crypto lobby groups is pressuring Congress to keep a key tax bill’s language intact for staking and mi...
North America’s World Cup kickoff puts press freedom under the spotlight. CPJ warns that cpj: press freedom must endu...
Oil prices retreat in mid-2026, but mortgage rates haven’t followed, leaving borrowers facing higher payments. Here's...
U.S. airline stocks rise on easing fuel costs, led by American Airlines and United, as crude prices slip and margins ...
Geopolitical tensions around Iran are pushing oil volatility and, in turn, accelerating EV adoption. Analysts warn th...
Marvell posts solid AI-driven growth but thinner margins, while Broadcom preserves elite margins and software, unders...
CoreWeave stock moves in a volatile path as a growing backlog and AI partnerships underpin a potential upside. This a...
OpenAI is quietly pitching its products to U.S. military and national security clients, a move that could reshape fun...
Broadcom’s surge in AI-driven sales dwarfs Marvell’s growth, setting a clear benchmark for the AI boom. The contrast ...
Microsoft leads a renewed sector rotation as AI momentum and stable cloud revenue lift its outlook, while Intel stumb...
Cadence Design Systems posted a strong Q1 FY2026, underscoring a rising demand for AI chip design tools. A record bac...